Beiersdorf : Generation change in R&D management

Since 2014, May Shana'a has been leading the Beiersdorf R&D organization, driving successful key innovations and significantly expanding regional capabilities and reach. 'Under her leadership, extensive progress has been achieved in areas like alternative testing, epigenetics, and the human microbiome,' said Stefan De Loecker. May Shana'a has been instrumental in bringing one of Beiersdorf's biggest innovative ingredient successes ever to life - Thiamidol. The highly effective active disrupted the anti-pigment market and secured significant gains for the EUCERIN Derma business. During the same period, R&D teams under her leadership have been one of the key pillars of Beiersdorf's sustainability agenda, achieving breakthroughs in sustainable product formulas and packaging, notably the exit from microplastics in formulas and the ongoing plastics reduction pledge.

Stefan De Loecker: 'We thank May Shana'a for her seven years of passionate and dedicated services to Beiersdorf. We wish her all the very best in the new phase of her life, after completing a highly commendable international career.'

'To end my executive management career by serving NIVEA and EUCERIN for the last seven years has been a special privilege. I am proud of my global R&D Team and the successes we have created together. I thank all my fellow Beiersdorf colleagues and stakeholders for supporting me since the very beginning. I wish my successor Gitta Neufang with the R&D community great success in creating the next episode of innovation at Beiersdorf,' says May Shana'a.